Noelle K. Eder - 14 May 2024 Form 4 Insider Report for Cigna Group (CI)

Role
EVP, Global Chief Information Officer
Signature
Matthew Arnold, attorney-in-fact
Issuer symbol
CI
Transactions as of
14 May 2024
Net transactions value
-$2,630,394
Form type
4
Filing time
16 May 2024, 17:22:42 UTC
Previous filing
05 Mar 2024
Next filing
07 Jan 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CI Common Stock, $.01 Par Value Options Exercise $948,273 +5,533 +26% $171.38 26,524 14 May 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Sale $3,728,629 -10,700 -40% $348.47 15,824 14 May 2024 Direct F1
transaction CI Common Stock, $.01 Par Value Options Exercise $149,962 +875 +5.5% $171.38 16,699 15 May 2024 Direct F1
holding CI Common Stock, $.01 Par Value 176 14 May 2024 By 401(k) F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -5,533 -86% $0.000000 875 14 May 2024 Common Stock, $.01 Par Value 5,533 $171.38 Direct F1, F3
transaction CI Employee Stock Option (Right to Buy) Options Exercise $0 -875 -100% $0.000000* 0 15 May 2024 Common Stock, $.01 Par Value 875 $171.38 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2024.
F2 Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
F3 This option was granted on September 14, 2020. The option vested in two equal annual installments on the first and second anniversaries of the grant date.

Remarks:

EVP, Global Chief Information Officer